With these cut-off points, CSNK2A1-positivity was significantly associated with sex (p = 0.046), higher tumor stage (p = 0.006), higher T category (p = 0.028), higher M category (p = 0.047), latent distant metastasis (p = 0.025), and pSIRT6-positivity (p < 0.001) (Table 1). The gene discussed is CSNK2A1; the disease is neoplasm.